Cargando…

The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Barth, Rolf F., Buja, L. Maximillian, Parwani, Anil V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359764/ https://www.ncbi.nlm.nih.gov/pubmed/32665025 http://dx.doi.org/10.1186/s13000-020-00999-9

Ejemplares similares

Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
por: Martines, Roosecelis B., et al.
Publicado: (2020)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Special Issue “SARS-CoV-2: Epidemiology and Pathogenesis”: Editorial
por: Calistri, Paolo, et al.
Publicado: (2023)

Next generation diagnostic pathology: use of digital pathology and artificial intelligence tools to augment a pathological diagnosis
por: Parwani, Anil V.
Publicado: (2019)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge
por: Mohanty, Sambit K., et al.
Publicado: (2020)

Electron microscopic identification of SARS-CoV-2
por: Buja, Louis Maximilian
Publicado: (2021)

JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis
por: Son, Juhee, et al.
Publicado: (2021)

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
por: Son, Juhee, et al.
Publicado: (2022)

A novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021
por: Buja, Louis Maximilian, et al.
Publicado: (2021)

Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2
por: Saadi, Fareeha, et al.
Publicado: (2021)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
por: Ma, Cuiqing, et al.
Publicado: (2020)

Introducing the Journal of Pathology Informatics
por: Pantanowitz, Liron, et al.
Publicado: (2010)

The novel Coronavirus (SARS-CoV-2) is a one health issue
por: Marty, Aileen Maria, et al.
Publicado: (2020)

Le SARS-CoV-2 : un coronavirus comme les autres ?
por: Morand, A., et al.
Publicado: (2021)

Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review
por: Mondello, Cristina, et al.
Publicado: (2021)

Journal of Pathology Informatics thanks its reviewers
por: Pantanowitz, Liron, et al.
Publicado: (2014)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Accessory proteins of SARS-CoV and other coronaviruses
por: Liu, Ding Xiang, et al.
Publicado: (2014)

Sensitive detection of anti‐spike antibodies enables improved understanding of SARS‐CoV‐2 pathogenesis
por: Milling, Simon
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2
por: Badi, Sara Ahmadi, et al.
Publicado: (2022)

Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical/Dermoscopical Findings: Where We Are and Where We Will Go
por: Cazzato, Gerardo
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Molecular Advances in SARS-CoV-2: A Brief Update on Transmission, Infection, and Pathology Aspects
por: Mesquita, João R.
Publicado: (2022)

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations
por: Jha, Niraj Kumar, et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Special Issue “Viral and Host Factors Driving the Emergence and the Evolution of the SARS-CoV-2 and Other Coronaviruses”
por: Ronfort, Corinne
Publicado: (2022)

Interactomes of SARS‐CoV‐2 and human coronaviruses reveal host factors potentially affecting pathogenesis
por: Chen, Zhen, et al.
Publicado: (2021)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e0npheqgiiga9ppjpn8547r3k